IP6K2 and glioma: In general, we propose that LINC00467 could inhibit p53 expression in the nucleus by binding to DNMT1, while it might promote IP6K2 expression by binding to miR-339-3p in the cytoplasm, thereby promoting the malignant growth and metastasis of gliomas (Figure 6).